KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 11 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,548,000 | -21.9% | 11,460,000 | -23.4% | 0.77% | -17.1% |
| Q4 2021 | $12,230,000 | +6.9% | 14,960,000 | 0.0% | 0.93% | -13.5% |
| Q3 2021 | $11,437,000 | -23.9% | 14,960,000 | -0.3% | 1.07% | -33.4% |
| Q2 2021 | $15,028,000 | +60.4% | 15,000,000 | +66.7% | 1.61% | +40.9% |
| Q1 2021 | $9,367,000 | – | 9,000,000 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,000,000 | $15,028,000 | 1.61% |
| Context Capital Management, LLC | 13,000 | $13,039,000 | 1.21% |
| STEELHEAD PARTNERS LLC | 14,000,000 | $13,941,000 | 0.92% |
| PenderFund Capital Management Ltd. | 3,000,000 | $3,754,000 | 0.88% |
| AQR Arbitrage LLC | 7,000,000 | $7,021,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $19,960,000 | 0.16% |
| CSS LLC/IL | 2,000,000 | $1,991,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,000,000 | $10,456,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $17,552,000 | 0.02% |
| Daiwa Securities Group Inc. | 3,000,000 | $3,004,000 | 0.02% |